Leigh Syndrome Research Update

Abliva’s Drug Candidate NV354 Granted Orphan Drug Designation for the Treatment of Mitochondrial Disease including a type of leukodystrophy called Leigh Syndrome

To read the press release: https://abliva.com/news/ablivas-drug-candidate-nv354-granted-orphan-drug-designation-for-the-treatment-of-mitochondrial-disease/